Clinical Trial Update: Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for asciminib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase, currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive | Phase 2 | Status: RECRUITING